tiprankstipranks
GT Biopharma Announces CFO Transition and New Financial Leadership
Company Announcements

GT Biopharma Announces CFO Transition and New Financial Leadership

Don't Miss Our Christmas Offers:

An update from GT Biopharma (GTBP) is now available.

GT Biopharma, Inc. has made a significant change in its executive team by terminating Manu Ohri as Chief Financial Officer and appointing the experienced Alan L. Urban to the role. Urban brings a wealth of knowledge from previous CFO roles across various sectors, including financial technology and cryptocurrency mining, and holds an extensive background in finance and accounting. Under the new employment agreement effective June 3, 2024, Urban will earn a substantial annual salary with potential bonuses, receive stock awards, and be entitled to severance under certain conditions, highlighting the company’s strategic move to strengthen its financial leadership.

See more insights into GTBP stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyGT Biopharma initiated with a Buy at Roth MKM
TheFlyGT Biopharma reports Q3 EPS ($1.53) vs. ($1.77) last year
TipRanks Auto-Generated NewsdeskGT Biopharma’s Dr. Miller Assumes New Medical Director Role
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App